Deepali Rishipathak

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe Yuen, Lifen Liu, Vinita Gupta et al. · Nature Medicine · 2020 · 439 citations · Full text

Life Sciences, Immunology, Oncology +16

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Differential increase in the expression of heat shock protein family members during sleep deprivation and during sleep

Akira Terao, Teresa L. Steininger, Karim Hyder et al. · Neuroscience · 2003 · 147 citations

Life Sciences, Molecular Biology, Neurobiology +15

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors

Tae Won Kim, Howard A. Burris, Maria J. de Miguel et al. · Clinical Cancer Research · 2022 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Single-cell analysis reveals clonally expanded tumor-associated CD57 ⁺ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade

Michael Fehlings, Leesun Kim, Xiangnan Guan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 54 citations · Full text

Life Sciences, Immunology, Oncology +17